Apremilast Decreased Proinflammatory Cytokines and Subsequently Increased Inhibitory ones in Psoriasis: A Prospective Cohort Study

Acta Derm Venereol. 2024 May 13:104:adv37555. doi: 10.2340/actadv.v104.37555.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Cytokines* / metabolism
  • Female
  • Humans
  • Inflammation Mediators / metabolism
  • Male
  • Middle Aged
  • Phosphodiesterase 4 Inhibitors / therapeutic use
  • Prospective Studies
  • Psoriasis* / drug therapy
  • Psoriasis* / immunology
  • Thalidomide* / analogs & derivatives
  • Thalidomide* / therapeutic use
  • Treatment Outcome

Substances

  • apremilast
  • Thalidomide
  • Cytokines
  • Anti-Inflammatory Agents, Non-Steroidal
  • Inflammation Mediators
  • Phosphodiesterase 4 Inhibitors